Insider filing · EWTX
John R Moore
General Counsel
profile →
Edgewise Therapeutics, Inc.
EWTX · Healthcare · 28 filings in 24 months
ticker →
John R Moore sold $2.0M of Edgewise Therapeutics (EWTX)
Executed Sep 20 2024, disclosed Sep 24 2024, 4 days later.
Value, as filed
$2.0M
70,922 sh across 2 lots
Executed
Sep 20 2024
the trade date, as filed
Disclosed
Sep 24 2024
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JMJohn R Moore (General Counsel) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Edgewise Therapeutics, Inc. (EWTX). The largest single filing was $213K of EWTX (4,858 sh across 2 lots, as filed), executed Aug 12.
The name
EWTXHealthcare · Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle dis…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John R Moore in EWTX
EWTXSALE
Edgewise Therapeutics, Inc.
$213K4,858 sh across 2 lots
Exec Aug 12
Filed Aug 14 · 4:53 PM ET